Related Experiment Video
Updated: May 17, 2026

13:00
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
Published on: July 31, 2021
Individual cow's milk allergens as prognostic markers for tolerance development?
B Ahrens1, L C Lopes de Oliveira, L Grabenhenrich
1Department of Pediatric Pneumology and Immunology, Charité, Universitätsmedizin, Berlin, Germany.
Summary
Low levels of cow
Area of Science:
- Allergy and Immunology
- Pediatric Allergy
- Clinical Diagnostics
Background:
- Cow's milk allergy (CMA) is a prevalent food allergy in early childhood.
- Most children outgrow CMA, but predicting tolerance development is challenging.
- Lack of reliable prognostic markers hinders personalized management of CMA.
Purpose of the Study:
- To evaluate if IgE levels to specific cow's milk allergens can predict tolerance development.
- To identify reliable biomarkers for distinguishing persistent CMA from outgrown CMA.
- To assess the utility of component-resolved diagnostics in predicting CMA prognosis.
Main Methods:
- Followed 52 children diagnosed with CMA via DBPCFC.
- Assessed specific IgE, IgG, and IgG4 to crude cow's milk protein and individual allergens.
- Performed serial serological analysis prior to repeated oral food challenges.
Main Results:
- Low levels of IgE to cow's milk (CM)-specific IgE, α-lactalbumin, β-lactoglobulin, κ-casein, and α(s1)-casein correlated with outgrowing CMA.
- IgE levels to total casein, lactoferrin, β-casein, and β-lactoglobulin (Bos d5.0101) did not show significant correlation.
- Specific IgG and IgG4 levels were not useful predictors of tolerance development.
Conclusions:
- CM-specific IgE, particularly to individual allergens, serves as a valuable prognostic marker for CMA persistence.
- Component-resolved diagnostics offer similar predictive value but may not be cost-effective for routine use.
- Measurement of specific IgG or IgG4 antibodies is not recommended for predicting tolerance in CMA.
Related Concept Videos
Allergic Reactions
Overview
Cross-reactivity
Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
